Breast Cancer Related Lymphedema Clinical Trial
Official title:
A Feasibility Study Evaluating Flexitouch® Plus With a Therapy Cycle Software Modification in Patients With Unilateral Breast Cancer-Related Lymphedema (BCRL)
NCT number | NCT04073823 |
Other study ID # | 4070 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | January 23, 2020 |
Est. completion date | February 8, 2020 |
Verified date | January 2023 |
Source | Tactile Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of the study is to demonstrate equivalency in treatment effect, as determined by objective measurements, between the modified therapy cycle software and the FDA-cleared Flexitouch therapy cycle software.
Status | Terminated |
Enrollment | 2 |
Est. completion date | February 8, 2020 |
Est. primary completion date | February 8, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Female 18 years of age or older - Diagnosis of unilateral breast cancer-related lymphedema - Stage I or early stage II lymphedema without severe fibrosis at the time of enrollment - = 5% volume difference between affected and unaffected arm as verified via perometry - Willing and able to give informed consent - Willing and able to comply with the study protocol requirements and all study-related visit requirements Exclusion Criteria: - In-home use of PCD within previous 3 months - Therapist or self-administered manual lymph drainage (MLD) within previous 1 week - Mastectomy or lymph node removal on side without lymphedema - Bilateral lymphedema - Heart failure (acute pulmonary edema, decompensated acute heart failure) - Acute venous disease (acute thrombophlebitis, acute deep venous thrombosis, acute pulmonary embolism) - Active skin or limb infection/inflammatory disease (acute cellulitis, other uncontrolled skin or untreated inflammatory skin disease) on the arms or trunk - Active cancer (cancer that is currently under treatment, but not yet in remission) - Poorly controlled kidney disease (glomerular filtration rate < 30 mls per minute), hypoproteinemia, pulmonary hypertension, hypothyroidism, cyclic edema, or Munchausen Syndrome - BMI >50 - Any circumstance where increased lymphatic or venous return is undesirable - Currently pregnant or trying to become pregnant - Allergy to iodine |
Country | Name | City | State |
---|---|---|---|
United States | University of Texas Health Science Center at Houston | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
Tactile Medical |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Lymphatic Activation | Comparison of the change in the rate of lymphatic propulsion events from the pre-treatment values to the post-treatment values for both the affected and contralateral limbs using the investigational technique of near infrared-fluorescent (NIRF) imaging. | Baseline and following a single treatment, an average of one hour | |
Primary | Changes in Swelling - MoistureMeterD | Comparison of the percent change in local tissue water from the pre-treatment values to the post-treatment values on the affected limb using MoistureMeterD. | Baseline and following a single treatment, an average of one hour | |
Primary | Changes in Swelling - Perometry | Swelling in the affected and contralateral limb as assessed using local tissue water content | Baseline and following a single treatment, an average of one hour | |
Primary | Percent Change in Skin Thickness From Baseline to After Treatment. | Skin changes on the affected and contralateral limb as assessed by skin thickness (Ultrasound). | Baseline and following a single treatment, an average of one hour | |
Primary | Incidence of Adverse Events | Adverse events reported between treatment and the 24-hour follow-up | 24-Hour Follow-Up | |
Primary | Post-Treatment Functional Vessel Assessment Via Near Infrared-fluorescent (NIRF) Imaging | Comparison of the number of subjects with an increase in vessels for both the affected and contralateral limbs via near infrared-fluorescent (NIRF) imaging. | Baseline and following a single treatment, an average of one hour | |
Primary | Projected Area or Extent of Dermal Backflow Via Near Infrared-fluorescent (NIRF) Imaging | Comparison of the change in dermal backflow from the pre-treatment values to the post-treatment values as the sum of the volume of area for all locations for both the affected and contralateral limbs via near infrared-fluorescent (NIRF) imaging | Baseline and following a single treatment, an average of one hour | |
Primary | Swelling in the Affected and Contralateral Limb as Assessed Using: Perometry (LymphaTech 3D Scanner) | Compare the percent of participants by arm demonstrating a decrease in limb volume for the affected and contralateral limbs via Perometry (LymphaTech 3D Scanner) | Baseline and following a single treatment, an average of one hour | |
Primary | Skin Changes on the Affected and Contralateral Limb as Assessed by: Skin Thickness (Ultrasound) | Comparison of the percent of participants by arm demonstrating a decrease in thickness for each site, separating skin and subcutaneous changes, on the affected limb via Ultrasound | Baseline and following a single treatment, an average of one hour | |
Primary | Absolute Change in Skin Thickness From Baseline to After Treatment | Skin Changes on the affected and contralateral limb as assessed by skin thickness (Ultrasound). | Baseline and following a single treatment, an average of one hour. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06065423 -
Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related Lymphedema
|
N/A | |
Completed |
NCT05058495 -
The Effect of Mobile Lymphedema Self-Care Support Program on Self-Care in Women With Breast Cancer-related Lymphedema
|
N/A | |
Recruiting |
NCT05682885 -
The Effectiveness of Lymphatic Bypass Supermicrosurgery
|
N/A | |
Recruiting |
NCT04824378 -
Study on Classification Method of Indocyanine Green Lymphography Based on Deep Learning
|
||
Active, not recruiting |
NCT04872738 -
Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment
|
||
Completed |
NCT05776433 -
The Effects of Upper Extremity Lymphedema on Posture, Upper Extremity Functions, and Quality of Life
|
||
Active, not recruiting |
NCT05022823 -
Exercise and Compression for Lymphedema
|
N/A | |
Recruiting |
NCT04446494 -
Identification and Preservation of Arm Lymphatics
|
N/A | |
Completed |
NCT04881604 -
Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema
|
N/A | |
Recruiting |
NCT04934098 -
Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema
|
N/A | |
Enrolling by invitation |
NCT04165512 -
Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema
|
N/A | |
Not yet recruiting |
NCT06182046 -
Effect of BOSU Exercises Added to Complete Decongestive Treatment on Balance in Breast Cancer-associated Lymphedema.
|
N/A | |
Recruiting |
NCT04690439 -
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
|
N/A | |
Recruiting |
NCT04665882 -
Nomogram to Predict Breast Cancer Related Lymphedema
|
N/A | |
Completed |
NCT04659564 -
Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study
|
N/A |